BIOTECHNOLOGY VALUE FUND L P

Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Shares Owned: 5,769,231 shares
Security Ownership %: 3.5%

BVF PARTNERS L P/IL ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

09 Jul 2025 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,769,231 shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 3.5% ownership of the company. In their previous filing dated 09 Jul 2025, BIOTECHNOLOGY VALUE FUND L P had reported owning 11,538,462 shares, indicating a decrease of +50%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BVF PARTNERS L P/IL	3.5%	-47%	$17,250,001	5,769,231	-5,769,231	-50%	$2.99	13G/A	03 Jul 2025	09 Jul 2025, 19:55
BVF PARTNERS L P/IL	6.8%		$34,500,001	11,538,462			$2.99	13G/A	30 Jun 2025	09 Jul 2025, 19:53